GuptaAKVersteegSGShearNH. Confirmatory testing prior to initiating onychomycosis therapy is cost-effective [published online September 1, 2017]. J Cutan Med Surg.
2.
MikailovACohenJJoyceCMostaghimiA. Cost-effectiveness of confirmatory testing before treatment of onychomycosis. JAMA Dermatol. 2016;152(3):276.
National Library of Medicine–National Institute of Diabetes and Digestive and Kidney Disease. LiverTox: clinical and research information on drug-induced liver injury: drug record: terbinafine. https://livertox.nlm.nih.gov/Terbinafine.htm. Accessed October 23, 2017.